Tox has been on my radar screen for a while - it's a company with a clear strategic vision operating in a growing market. I've held back from buying (so far) because (1) the prevailing share price IMHO priced in most of the near term growth potential and (2) the company raised capital in a manner which diluted shareholder equity (i.e. destroyed shareholder value).
I still like the story and the strategic vision but the recent result was disappointing both in terms of what the company delivered and for the lack of granularity on the outlook.
I'll continue to follow the company but would need either a better value proposition (i.e. a lower share price) or some more robust and specific guidance on the outlook.
- Forums
- ASX - By Stock
- TOX
- Ann: FY17 Half Year Results Presentation
Ann: FY17 Half Year Results Presentation, page-6
-
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)